
2023 EVENTS

WHO WE ARE
The Life Sciences Collaborative is a select group of industry veterans and executives from the pharmaceutical, biotechnology, and medical device sectors and industry service providers who share a common vision of increasing the success.
LSC activities are built around small, informal, monthly breakfast educational and networking meetings. These sessions focus on topics around innovation and investment, including industry trends, practical issues related to growing and managing innovative businesses, and best practices.
OUR PARTNERS






MISSON STATEMENT
The mission of the Life Sciences Collaborative is to promote connectivity among leaders in emerging life sciences businesses through networking, education, training, and mentorship with the goal of advancing professionals.
LSC is a volunteer organization. It is neither sponsorship nor membership dues driven. If you are interested in participating in LSC’s monthly breakfast meetings, please contact us.

MISSON STATEMENT
The mission of the Life Sciences Collaborative is to promote connectivity among leaders in emerging life sciences businesses through networking, education, training, and mentorship with the goal of advancing professional.
LSC EVENTS
The meetings also include presentations by emerging companies, providing them with
opportunities to get expert feedback on their technologies and to expand their networks.
Life Sciences Collaborative Networking Meeting
Life Sciences Collaborative Networking Breakfast at BIO 2023
Innovators and Investors: The Journey from Entry to Exit
Opportunities in a Changing Life Sciences Landscape
Healthcare Key Trends Influencing The Life Sciences Industry
Why Invest in Philadelphia Now? – Converting Risk Capital to Success Stories
An Ounce of Prevention – Risk Management Strategies for Life Sciences and Healthcare Technology Companies
Achievement Beyond Regulatory Approval – Design for Commercial Success
Achievement Start-up to Exit – Lessons for Success
LSC MEMBERS
CEOs, Directors, Private Equity and Venture Partners, Angel Investors
Members may have successful track record leading public or private companies.
David Barone
Boston Medtech Advisors
David Kerr
Position: Vice President Business Development; Syneos Health Commercial Solutions
Categories: 2. EVENT COMMITTEE, King of Prussia, PA
David Kerr
Vice President Business Development; Syneos Health Commercial Solutions
Dawn Flitcraft
Position: Chief M&A Intergration Officer; WCG Clinical
Categories: 3. EXECUTIVE OFFICERS, King of Prussia, PA
Dawn Flitcraft
Chief M&A Intergration Officer; WCG Clinical
Ellen Derrico
Marketing Consultant
Eric Silver, Ph.D
Imagine Scientific, Inc.
Erika Geimonen
Position: Vice President, Business Development; Amring Pharmaceuticals
Categories: 2. EVENT COMMITTEE, King of Prussia, PA
Erika Geimonen
Vice President, Business Development; Amring Pharmaceuticals
Eshwar Inapuri
Position: Chief Executive Officer; Innamed
Categories: 3. EXECUTIVE OFFICERS, King of Prussia, PA
Eshwar Inapuri
Chief Executive Officer; Innamed
Fred Meyer, Ph.D
Position: CicloMed
Categories: 1. CO-CHAIR, 2. PLANNING COMMITTEE, 3. EXECUTIVE OFFICERS, 3. MEMBERS, Boston, MA
Fred Meyer, Ph.D
CicloMed
Greg Ambra, MS, MBA
Position: Independent Consultant l Clinical Development Advisor
Categories: 2. PLANNING COMMITTEE, LSC – New Jersey
Greg Ambra, MS, MBA
Independent Consultant l Clinical Development Advisor
Greg Baker
Boston Children's Hospital
Greg House
Position: Principle; Real World Outcomes LLC
Categories: 2. EVENT COMMITTEE, King of Prussia, PA
Greg House
Principle; Real World Outcomes LLC
Glenn Whaley
Position: Chief Financial Officer at Immunic Therapeutics (Nasdaq:IMUX)
Categories: 3. MEMBERS, LSC – New Jersey
Glenn Whaley
Chief Financial Officer at Immunic Therapeutics (Nasdaq:IMUX)
Harry Atkins
Position: Senior Director, Alliance Management; Incyte Corporation
Categories: 2. EVENT COMMITTEE, King of Prussia, PA
Harry Atkins
Senior Director, Alliance Management; Incyte Corporation
Ihor Terleckyj, Ph.D.
Position: Chief Executive Officer; CuRAGE Therapeutics
Categories: LSC – New Jersey
Ihor Terleckyj, Ph.D.
Chief Executive Officer; CuRAGE Therapeutics
Ira Spector
CEO at SFA Therapeutics, Inc
Jack Foster
Position: Vice President of Finance; InClinica, Inc.
Categories: 2. EVENT COMMITTEE, King of Prussia, PA
Jack Foster
Vice President of Finance; InClinica, Inc.
JeanMarie Markham
Consultant / Independent Board Director
Jeremy Sohn
p74 Ventures
WHAT OUR MEMBERS SAY

“The LSC has given me instant access to a number of subject matter experts as well new connections to colleagues up and down the East Coast!”

“I learn something new and valuable at every LSC event. I’ve been able to make new connections & friends in every aspect of the ecosystem.”

“I learn something new and valuable at every LSC event. I’ve been able to make new connections & friends in every aspect of the ecosystem.”